Dec 11, 2025 · Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated …

1 day ago · Illumina congratulates Everett Cunningham on appointment Illumina also announced the departure of chief commercial officer Everett Cunningham, who has been appointed as …

2 days ago · Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research software platform to analyze and visualize …

Dec 26, 2025 · Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.

Mar 4, 2025 · Illumina, which is one of San Diego’s largest public companies, had just under 9,000 full-time employees globally as of Dec. 29, 2024.

We are Illumina We are a global genomics and human health leader innovating the future of precision health. We develop DNA sequencing and array-based life sciences technologies to …

4 days ago · Illumina, Inc NASDAQ: ILMN is a global life sciences company that develops, manufactures and markets integrated systems for the analysis of genetic variation and function.

Apr 3, 2023 · The decision reverses an administrative judge's ruling that dismissed the FTC's initial challenge of Illumina's $7.1 billion Grail deal.

Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications.